Episode Details

Mika Newton and Tom Neyarapally explore how advancements in AI are accelerating the development of new algorithms, improving target discovery, and enhancing high-throughput screening. The conversation highlights the challenges and opportunities in aggregating innovative technologies, the convergence of AI tools in healthcare, and the potential for personalized and economically viable drug development.